Leveraging electronic health records for data science: common pitfalls and how to avoid them

被引:57
作者
Sauer, Christopher M. [1 ,2 ]
Chen, Li-Ching [3 ]
Hyland, Stephanie L. [4 ]
Girbes, Armand [1 ]
Elbers, Paul [1 ]
Celi, Leo A. [2 ,5 ,6 ]
机构
[1] Amsterdam UMC, Locat VUmc, Lab Crit Care Computat Intelligence,Amsterdam Ins, Amsterdam Med Data Sci,Amsterdam Cardiovasc Sci,D, NL-1081 HV Amsterdam, Netherlands
[2] MIT, Lab Computat Physiol, Inst Med Engn & Sci, Cambridge, MA USA
[3] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu, Taiwan
[4] Microsoft Res, Cambridge, England
[5] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA
[6] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA USA
来源
LANCET DIGITAL HEALTH | 2022年 / 4卷 / 12期
基金
美国国家卫生研究院;
关键词
INTERNATIONAL CONSENSUS DEFINITIONS; SELECTION BIAS; SEVERE SEPSIS; DATA QUALITY; CARE; EPIDEMIOLOGY; GUIDELINES; TRIALS;
D O I
10.1016/S2589-7500(22)00154-6
中图分类号
R-058 [];
学科分类号
摘要
Analysis of electronic health records (EHRs) is an increasingly common approach for studying real-world patient data. Use of routinely collected data offers several advantages compared with other study designs, including reduced administrative costs, the ability to update analysis as practice patterns evolve, and larger sample sizes. Methodologically, EHR analysis is subject to distinct challenges because data are not collected for research purposes. In this Viewpoint, we elaborate on the importance of in-depth knowledge of clinical workflows and describe six potential pitfalls to be avoided when working with EHR data, drawing on examples from the literature and our experience. We propose solutions for prevention or mitigation of factors associated with each of these six pitfalls-sample selection bias, imprecise variable definitions, limitations to deployment, variable measurement frequency, subjective treatment allocation, and model overfitting. Ultimately, we hope that this Viewpoint will guide researchers to further improve the methodological robustness of EHR analysis.
引用
收藏
页码:E893 / E898
页数:6
相关论文
共 72 条
  • [1] Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)
    Alikhan, Raza
    Bedenis, Rachel
    Cohen, Alexander T.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05):
  • [2] Amin Alpesh, 2019, Drugs Context, V8, P212568, DOI 10.7573/dic.212568
  • [3] Machine learning for patient risk stratification: standing on, or looking over, the shoulders of clinicians?
    Beaulieu-Jones, Brett K.
    Yuan, William
    Brat, Gabriel A.
    Beam, Andrew L.
    Weber, Griffin
    Ruffin, Marshall
    Kohane, Isaac S.
    [J]. NPJ DIGITAL MEDICINE, 2021, 4 (01)
  • [4] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [5] Bonomi S., 2016, Information and Communication Technologies in Organizations and Society, P33, DOI DOI 10.1007/978-3-319-28907-6_3
  • [6] Addressing Bias in Electronic Health Record-based Surveillance of Cardiovascular Disease Risk: Finding the Signal Through the Noise
    Julie K. Bower
    Sejal Patel
    Joyce E. Rudy
    Ashley S. Felix
    [J]. Current Epidemiology Reports, 2017, 4 (4) : 346 - 352
  • [7] Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures
    Brumback, BA
    Hernán, MA
    Haneuse, SJPA
    Robins, JM
    [J]. STATISTICS IN MEDICINE, 2004, 23 (05) : 749 - 767
  • [8] Severe Sepsis and Septic Shock
    Moreira, Jose
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (21) : 2063 - 2063
  • [9] Randomized Clinical Trial Representativeness and Outcomes in Real-World Patients: Comparison of 6 Hallmark Randomized Clinical Trials of Relapsed/Refractory Multiple Myeloma
    Chari, Ajai
    Romanus, Dorothy
    Palumbo, Antonio
    Blazer, Marlo
    Farrelly, Eileen
    Raju, Aditya
    Huang, Hui
    Richardson, Paul
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (01) : 8 - +
  • [10] Choi Edward, 2016, JMLR Workshop Conf Proc, V56, P301